Challenges of antituberculosis treatment in patients with difficult clinical conditions
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F15%3A%230001156" target="_blank" >RIV/00064190:_____/15:#0001156 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1111/crj.12119" target="_blank" >http://dx.doi.org/10.1111/crj.12119</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/crj.12119" target="_blank" >10.1111/crj.12119</a>
Alternative languages
Result language
angličtina
Original language name
Challenges of antituberculosis treatment in patients with difficult clinical conditions
Original language description
Tuberculosis (TB) is an infectious disease with a global distribution. The mainstay of treatment is a combination of antituberculous (AT) drugs. The standard combination uses four first-line AT drugs; however, in certain groups of patients, the combination must be modified or reduced in dosage. This is especially true of patients with comorbidities, in the elderly and in pregnant women. The aim of this review is to provide up-to-date information regarding AT treatment in a variety of special patient populations.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FC - Pneumology
OECD FORD branch
—
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
The clinical respiratory journal
ISSN
1752-6981
e-ISSN
—
Volume of the periodical
9
Issue of the periodical within the volume
2
Country of publishing house
GB - UNITED KINGDOM
Number of pages
9
Pages from-to
142-152
UT code for WoS article
000352561500002
EID of the result in the Scopus database
—